Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04030325 · ClinicalTrials.gov registry record · NA
Motivating Campus Change Study
A NA study of Drinking Behavior, sponsored by University of Washington.
- Active
- Registry status
- NA
- Development phase
- 1,012
- Enrollment target
- 1
- Study location
NCT04030325: Active NA study of Drinking Behavior, sponsored by University of Washington.
NCT04030325 is a NA study of Drinking Behavior that is active but no longer recruiting, run by University of Washington. The registered enrollment target is 1,012 participants, above the 193-participant average among 7 other Drinking Behavior trials with a reported enrollment target (424% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04030325, a NA study of Drinking Behavior, is active but no longer recruiting, sponsored by University of Washington.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 1,012 participants
- Enrollment target
- 1
- Study location
Study Summary
The study evaluates the relative merit of a multi-component PFI presented in the traditional simultaneous delivery (i.e., all components at once) versus a sequential format, wherein individual PFI components are delivered one at a time over several weeks to minimize time and attention demands for each component.
Primary Outcome
The first primary outcome of this program of research is to assess change in alcohol use from baseline to 6 months utilizing the Daily Drinking Questionnaire. The Daily Drinking Questionnaire assesses typical number of drinks on each of day of a typical week in the past month. Participants are allowed to enter the number of drinks for each day of the week. Values for each day will be summed together to create a composite score of typical weekly drinking. Minimum value is zero (0) and there is n
Conditions Studied
Interventions
- BEHAVIORAL Sequential Personalized Feedback Intervention Delivery
- BEHAVIORAL Simultaneous Personalized Feedback Intervention Delivery
- BEHAVIORAL Text Message Boosters
Study Locations (1)
Washington
- The Center for the Study of Health and Risk Behaviors - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,012 participants |
| Start Date | 2019-11-06 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the registry record for NCT04030325 still lists
NCT04030325 is an interventional study that assigns participants to a tested intervention. Its 1,012 participants enrollment target places it among the larger protocols in the corpus, above the 193-participant average among 7 other Drinking Behavior trials with a reported enrollment target (424% higher).
The record links to 1 condition, with Drinking Behavior appearing as the primary indexed condition, and to 3 interventions - of which Sequential Personalized Feedback Intervention Delivery is the first listed.
NCT04030325 reports a single indexed study location in Washington.
Frequently Asked Questions
What is clinical trial NCT04030325 about?
NCT04030325 is a clinical study titled "Motivating Campus Change Study". The study evaluates the relative merit of a multi-component PFI presented in the traditional simultaneous delivery (i.e., all components at once) versus a sequential format, wherein individual PFI components are delivered one at a time over several weeks to minimize time and attention demands for ea...
What is the current status of trial NCT04030325?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 1,012 participants. The study started on 2019-11-06. Estimated completion is 2025-06-30.
What conditions does trial NCT04030325 study?
This clinical trial studies the following conditions: Drinking Behavior.
What interventions are being tested in trial NCT04030325?
The interventions under investigation include: Sequential Personalized Feedback Intervention Delivery (BEHAVIORAL), Simultaneous Personalized Feedback Intervention Delivery (BEHAVIORAL), Text Message Boosters (BEHAVIORAL).
Who is sponsoring clinical trial NCT04030325?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04030325 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drinking Behavior
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Developing Functional Connectivity-Guided TMS for Alcohol Use Disorder
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention
ACTIVE NOT RECRUITING · NA
-
Barbershop Talk: Reducing Excessive Alcohol Consumption Among Men
ACTIVE NOT RECRUITING · NA
-
A Brief Intervention for Alcohol Users With Interpersonal Trauma
ACTIVE NOT RECRUITING · NA
-
Motivating Campus Change Project Pilot Study
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06146738 · 1,015 participants
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
- NCT06608823 · 1,016 participants · NA
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
- NCT07191782 · 1,008 participants · NA
Examining the Efficacy of the PRAISE With Coaching Program
- NCT06549595 · 1,018 participants · Phase 3
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI